Elevation of fibrinogen due to loss of ovarian function enhances actin ring formation and leads to increased bone resorption

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 11, 2012, Pages

  Ke, Ke ^a   Kim, Woon Ki ^a   Sul, Ok Joo ^a   Phan, Van Tien ^a   Lee, Mi Hyun ^a   Kim, Hyun Ju ^b   Kim, Shin Yoon ^b   Choi, Hye Seon ^a  

^a University of Ulsan   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

Bone loss; Osteoclast; Ovariectomy

Indexed keywords

ACTIN; BETA3 INTEGRIN; BIM PROTEIN; COLONY STIMULATING FACTOR 1; FIBRINOGEN; PROTEIN BCL 2; PROTEIN KINASE B; RAC1 PROTEIN; RAS PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL SURVIVAL; FEMALE; FIBRINOGEN BLOOD LEVEL; IN VITRO STUDY; MOUSE; NONHUMAN; ONCOGENE; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; OVARY FUNCTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ACTIN CYTOSKELETON; ACTINS; ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; FIBRINOGEN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE; RECEPTORS, VITRONECTIN; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; X-RAY MICROTOMOGRAPHY;

EID: 84870516530     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00085.2012     Document Type: Article

References (36)

1. Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung U, Fukuda A, Hikita A, Seto H, Okada T, Inaba T, Sanjay A, Baron R, Kawaguchi H, Oda H, Nakamura K, Strasser A, Tanaka S. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 24: 6653-6664, 2003.
2. Ariyoshi W, Takahashi T, Kanno T, Ichimiya H, Shinmyouzu K, Takano H, Koseki T, Nishihara T. Heparin inhibits osteoclastic differentiation and function. J Cell Biochem 103: 1707-1717, 2008.
3. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrinogen degradation products in atherosclerosis. Use of monoclonal antibodies. Atherosclerosis 9: 109-121, 1989.
4. Boissonnas CC, Montjean D, Lesaffre C, Auer J, Vaiman D, Wolf JP, Ziyyat A. Role of sperm alphavbeta3 integrin in mouse fertilization. Dev Dyn 239: 773-783, 2010.
5. Busso N, Peclat V, Van Ness K, Kolodziesczyk E, Degen J, Bugge T, So A. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest 102: 41-50, 1998.
6. Chellaiah MA, Soga N, Swanson S, McAllister S, Alvarez U, Wang D, Dowdy SF, Hruska KA. Rho-A is critical for osteoclast podosome organization, motility, and bone resorption. J Biol Chem 275: 11993-12002, 2000.
7. Dai XM, Ryan GR, Hapel AJ, Dominguez MG, Russell RG, Kapp S, Sylvestre V, Stanley ER. Targeted disruption of the mouse colony stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99: 111-120, 2002.
8. 3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. J Clin Invest 99: 2284-2292, 1997.
9. 3 integrin collaborate during osteoclast differentiation. J Clin Invest 111: 749-758, 2003.
10. 2 binding motif. J Clin Invest 117: 3224-3235, 2007.
11. Ford ES. The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. Atherosclerosis 168: 351-358, 2003.
12. Fuller K, Kirstein B, Chambers TJ. Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinol 147: 1979-1985, 2006.
13. Fuller K, Ross JL, Szewczyk KA, Moss R, Chambers TJ. Bone is not essential for osteoclast activation. PLoS ONE 5: e12837, 2010.
14. Glantschnig H, Fisher JE, Wesolowski G, Rodan GA, Reszka AA. M-CSF, TNF-α and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ 10: 1165-1177, 2003.
15. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 110: 673-687, 2002.
16. Inou M, Namba N, Chappel J, Teitelbaum SL, Ross FP. Granulocytemacrophage colony stimulating factor reciprocally regulates av-associated integrins on murine osteoclast precursors. Mol Endocrinol 12: 1955-1962, 1998.
17. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163: 434-442, 1999.
18. Kawamura N, Kugimiya F, Oshima Y, Ohba S, Ikeda T, Saito T, Shinoda Y, Kawasaki Y, Ogata N, Hoshi K, Akiyama T, Chen WS, Hay N, Tobe K, Kadowaki T, Azuma Y, Tanaka S, Nakamura K, Chung I, Kawaguchi H. Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS ONE 10: e1058, 2007.
19. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116: 2152-2160, 2006.
20. 3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 105: 433-440, 2000.
21. Pacific R. T cells and postmenopausal osteoporosis in murine models. Arthritis Res Ther 9: 102-106, 2007.
22. Roodman GD. Advances in bone biology: the osteoclast. Endocrinol Rev 17: 308-332, 1997.
23. 3 and macrophage colony stimulating factor: partners in osteoclast biology. Immun Rev 208: 88-105, 2005.
24. Sitrin RG, Pan PM, Srikanth S, Todd RFIII. Fibrinogen activates NF-kB transcription factors in monocuclear phagocytes. J Immunol 161: 1462-1470, 1998.
25. Sheng ZF, Xu K, Ma YL, Liu JH, Dai RC, Zhang YH, Jiang YB, Liao EY. Zoledronate reverses mandibular bone loss in osteoprotegrin-deficient mice. Osteoporosis Int 20: 151-159, 2009.
26. Shin HH, Lee JE, Lee EA, Kwon BS, Choi HS. Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10. J Bone Miner Res 21: 1907-1912, 2006.
27. Stachowiak GP, polac IK, Stetkiewicz TJ, Jedrzejczyk SC, Pertynski TS. Hematostatic variables of polish postmenopausal women. Singapore J Obstet Gynecol 33: 29-34, 2002.
28. Smiley ST, King JA, Hancock WW. Fibrinogen stimulatesmacrophage chemokine secretion through toll-like receptor 4. J Immunol 167: 2887-2894, 2001.
29. Sugatani T, Hruska KA. Akt1/Akt2 and mammalian target of rapamycin/ Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280: 3583-3589, 2005.
30. Sul OJ, Ke K, Kim WK, Kim SH, Lee SC, Kim HJ, Kim SY, Suh JH, Choi HS. Absence of MCP-1 leads to elevated bone mass via impaired actin ring formation. J Cell Physiol 227: 1619-1627, 2011.
31. Teitelbaum SL. Bone resorption by osteoclasts. Science 289: 1504-1508, 2000.
32. Torigo I, Sotome S, Tsuchiya A, Yoshii T, Maehara H, Sugata Y, Ichinose S, Shinomiya K, Okawa A. Bone regeneration with autologous plasma, bone marrow stromal cells, and porous beta-tricalcium phosphate in nonhuman primates. Tissue Eng Part A 15: 1489-1499, 2009.
33. Vorster HH. Fibrinogen and women's health. Thromb Res 95: 137-154, 1999.
34. Wells CM, Walmsley M, Ooi S, Tybulewicz V, Ridley AJ. Rac1-deficient macrophages exhibit defects in cell spreading and membrane ruffling but not migration. J Cell Sci 117: 1259-1268, 2004.
35. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116: 1186-1194, 2006.
36. Zhao H, Kitaura H, Sands MS, Ross FP, Teitelbaum SL, Novack DV. Critical role of beta3 integrin in experimental postmenopausal osteoporosis. J Bone Miner Res 20: 2116-2123, 2005.